We were interested in determining if heavily-mutated IgA sequences are increased in HIV-1 infection, as most broadly-neutralizing antibodies (bNAbs), a critical goal for HIV-1 vaccine development, have high mutation rates (49, 50). This evidence concerns the gene CD79A and HIV-1 infection.